{
    "clinical_study": {
        "@rank": "107727", 
        "acronym": "TICA KOREA", 
        "arm_group": [
            {
                "arm_group_label": "Ticagrelor", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Clopidogrel", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess safety and efficacy of Ticagrelor versus Clopidogrel\n      in Asian/KOREAn patients with acute coronary syndromes intended for invasive management."
        }, 
        "brief_title": "Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute Coronary Syndrome", 
            "Myocardial Ischemia", 
            "Heart Diseases", 
            "Cardiovascular Diseases", 
            "Angina Pectoris"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Angina Pectoris", 
                "Cardiovascular Diseases", 
                "Myocardial Ischemia", 
                "Coronary Artery Disease", 
                "Heart Diseases", 
                "Ischemia", 
                "Acute Coronary Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 and more\n\n          -  Index event of non-ST or ST segment elevation ACS\n\n          -  Provision of signed informed consent\n\n        Exclusion Criteria:\n\n          -  Hypersensitivity to aspirin or ticagrelor\n\n          -  Oral anticoagulation therapy that cannot be stopped\n\n          -  Treated with thrombolysis within 24hrs\n\n          -  Any other reason the investigator deems the subject to be unsuitable for the study\n             e.g., Active malignant tumor\n\n          -  Concomitant therapy with strong CYP3A inhibitors, CYP3A substrates with narrow\n             therapeutic index, or strong CYP3A inducers\n\n          -  Any life-threatening condition with life expectancy less than 6months\n\n          -  Mental condition (dementia, alcohol or drug abuse) which may be affect study\n             compliance or prevent understanding of the aims, investigational procedures or\n             possible consequences of the study\n\n          -  High risk due to malignant hypertension\n\n          -  The conditions associated with increased risk of bradycardiac events\n\n          -  Subjects with severe liver disease\n\n          -  Subjects requiring dialysis\n\n          -  Increased bleeding risk\n\n          -  History of cerebral hemorrhage, gastrointestinal bleeding within 6months, major\n             surgical procedure within 30days\n\n          -  Thrombocytopenia or leukopenia\n\n          -  Positive pregnancy test or is known to be pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02094963", 
            "org_study_id": "AMCCV2013-14"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ticagrelor", 
                "description": "180mg loading and 90mg bid", 
                "intervention_name": "Ticagrelor", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Clopidogrel", 
                "description": "600mg loading and 75mg qd", 
                "intervention_name": "Clopidogrel", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Clopidogrel", 
                "Ticagrelor"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "acute coronary syndrome", 
            "coronary disease", 
            "coronary artery disease"
        ], 
        "lastchanged_date": "March 23, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "state": "Songpa-gu", 
                        "zip": "138-736"
                    }, 
                    "name": "Asan Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucheon", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Soon Chun Hyang University Hospital Bucheon"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cheonan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Soon Chun Hyang University Hospital Cheonan"
                }
            }, 
            {
                "contact": {
                    "email": "siwanc@cnu.ac.kr", 
                    "last_name": "Si-Wan Choi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Dae-jeon", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Chungnam National University Hospital"
                }, 
                "investigator": {
                    "last_name": "Si-wan Choi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Daegu Catholic University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Keimyung University Dongsan Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gwangju", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Chonnam National University Hospital"
                }
            }, 
            {
                "contact": {
                    "email": "ptca@dongguk.ac.kr", 
                    "last_name": "Deuk-young Nah, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Gyeongju", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Dongguk University Gyeongju Hospital"
                }, 
                "investigator": {
                    "last_name": "Deuk-young Nah, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "im2pci@gmail.com", 
                    "last_name": "Sung-yun Lee, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Ilsan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Inje University Ilsan Paik Hospital"
                }, 
                "investigator": {
                    "last_name": "Sung-yun Lee, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Gachon University Gil Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jeonju", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "ChonBuk National University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pusan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Dong-A Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pusan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Inje University Pusan Paik Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Korea University Guro Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ulsan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Ulsan University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yangsan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Pusan National University Yangsan Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Open-label, Parallel Group, Multicenter Phase IV Study to Assess Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management:TICAKOREA Trial", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Safety of Ticagrelor compared to Clopidogrel by measuring the time to first occurrence of any bleeding event(including major, minor bleedings)", 
                "measure": "The time to first occurrence of any bleeding event", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "description": "Effect of Ticagrelor compared to Clopidogrel by measuring: time to first occurrence of any event from the composite of death from vascular causes, Myocardial Infarction (MI) and stroke", 
                "measure": "The time to first occurrence of any event from the composite of death from vascular causes, Myocardial Infarction (MI) and stroke", 
                "safety_issue": "No", 
                "time_frame": "1year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02094963"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Seung-Jung Park", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "by PLAtelet inhibition and patient Outcomes(PLATO) criteria", 
                "measure": "The time to first occurrence of major bleeding event", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "description": "by PLAtelet inhibition and patient Outcomes(PLATO) criteria", 
                "measure": "The time to first occurrence of minor bleeding event", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "description": "The Thrombolysis in Myocardial Infarction (TIMI) bleeding criteria", 
                "measure": "The time to first occurrence of major bleeding event or minor bleeding event", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "description": "The Thrombolysis in Myocardial Infarction (TIMI) bleeding criteria", 
                "measure": "The time to first occurrence of major bleeding event", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "description": "The Thrombolysis in Myocardial Infarction (TIMI) bleeding criteria", 
                "measure": "The time to first occurrence of minor bleeding event", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "description": "By Bleeding Academic Research Consortium(BARC) Definition of Bleeding Events", 
                "measure": "The time to first occurrence of Bleeding Academic Research Consortium (BARC)  bleeding event from type 1 to type 5", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "measure": "The time of first occurrence of discontinuation of study medication from any bleeding event", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "measure": "Non serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "measure": "Adverse events following discontinuation of study medication", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "measure": "Serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "1year"
            }, 
            {
                "description": "Effect of Ticagrelor compared to Clopidogrel by measuring: time to first occurrence of death from vascular causes", 
                "measure": "The time to first occurrence of death from vascular causes", 
                "safety_issue": "No", 
                "time_frame": "1year"
            }, 
            {
                "description": "Effect of Ticagrelor compared to Clopidogrel by measuring: time to first occurrence of myocardial infarction", 
                "measure": "The time to first occurrence of myocardial infarction", 
                "safety_issue": "No", 
                "time_frame": "1year"
            }, 
            {
                "description": "Effect of Ticagrelor compared to Clopidogrel by measuring: time to first occurrence of stroke", 
                "measure": "The time to first occurrence of stroke", 
                "safety_issue": "No", 
                "time_frame": "1year"
            }, 
            {
                "description": "The time to occurrence of composite events(death from any cause, myocardial infarction, stroke)", 
                "measure": "The time to occurrence of composite events", 
                "safety_issue": "No", 
                "time_frame": "1year"
            }, 
            {
                "measure": "The time to occurrence of death from any cause", 
                "safety_issue": "No", 
                "time_frame": "1year"
            }, 
            {
                "measure": "Number of patients with net clinical benefit of any total bleeding and any event from the composite of death from vascular causes, Myocardial Infarction and stroke.", 
                "safety_issue": "No", 
                "time_frame": "1year"
            }
        ], 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seung-Jung Park", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}